ANDA 76618, held by Chartwell RX. Paroxetine Hydrochloride.
As of Nov 21, 2026, ANDA 76618 (Paroxetine Hydrochloride), held by Chartwell RX, was first approved by FDA on Aug 15, 2005, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 15, 2005 | Original application | Approved | None posted |
| Paroxetine HydrochlorideEQ 10MG BASE · tablet;oral | Paroxetine Hydrochloride | Rx |
| Paroxetine HydrochlorideEQ 20MG BASE · tablet;oral | Paroxetine Hydrochloride | Rx |
| Paroxetine HydrochlorideEQ 30MG BASE · tablet;oral | Paroxetine Hydrochloride | Rx |
| Paroxetine HydrochlorideEQ 40MG BASE · tablet;oral | Paroxetine Hydrochloride | Rx |
| Jan 20, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Apr 20, 2020 | Supplement 21Labeling · Standard review | Approved | None posted |
| Dec 21, 2014 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 31, 2013 | Supplement 19Labeling · Standard review | Approved | None posted |
| Dec 27, 2011 | Supplement 18Labeling | Approved | None posted |
| Jul 27, 2011 | Supplement 17Labeling | Approved | None posted |
| Jan 21, 2011 | Supplement 16Labeling | Approved | None posted |
| Mar 25, 2010 | Supplement 15Labeling | Approved | None posted |
| Oct 15, 2009 | Supplement 13Labeling | Approved | None posted |
| Mar 16, 2009 | Supplement 10Labeling | Approved | None posted |
| Mar 16, 2009 | Supplement 11Labeling | Approved | None posted |
| Mar 16, 2009 | Supplement 12Labeling | Approved | None posted |
| Feb 27, 2008 | Supplement 7Labeling | Approved | None posted |
| Feb 27, 2008 | Supplement 9Labeling | Approved | None posted |
| Mar 29, 2007 | Supplement 3Labeling | Approved | None posted |
| Mar 24, 2006 | Supplement 1Labeling | Approved | None posted |
| Aug 15, 2005 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters